Growing evidences from both human and experimental studies revealed that impaired SIRT1 signaling is associated with alcoholic liver disease and genetic or pharmacological stimulations of SIRT1 protect against steatosis and/or steatohepatitis [44, 45]. The gene discussed is SIRT1; the disease is steatosis.